179 related articles for article (PubMed ID: 10918410)
1. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
Bönig H; Laws HJ; Wundes A; Verheyen J; Hannen M; Kim YM; Banning U; Nürnberger W; Körholz D
Bone Marrow Transplant; 2000 Jul; 26(1):91-6. PubMed ID: 10918410
[TBL] [Abstract][Full Text] [Related]
2. High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors.
Chan KW; Petropoulos D; Choroszy M; Herzog C; Jaffe N; Ater J; Korbling M
Bone Marrow Transplant; 1997 Dec; 20(12):1039-43. PubMed ID: 9466276
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
4. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
5. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
Pérez-Martínez A; Leung W; Muñoz E; Iyengar R; Ramírez M; Vicario JL; Lassaletta A; Sevilla J; González-Vicent M; Madero L; Díaz-Pérez MA
Pediatr Blood Cancer; 2009 Jul; 53(1):120-4. PubMed ID: 19215002
[TBL] [Abstract][Full Text] [Related]
6. Biology and treatment of pediatric malignant solid tumors.
Marina NM
Cancer Chemother Biol Response Modif; 1997; 17():642-71. PubMed ID: 9551234
[No Abstract] [Full Text] [Related]
7. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation (PBSCT) for refractory bone and soft tissue sarcomas].
Yonemoto T; Tatezaki S; Ishii T; Satoh T
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1431-5. PubMed ID: 10500530
[TBL] [Abstract][Full Text] [Related]
8. Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.
Drabko K; Zawitkowska-Klaczynska J; Wojcik B; Choma M; Zaucha-Prazmo A; Kowalczyk J; Gorczynska E; Toporski J; Kałwak K; Turkiewicz D; Chybicka A
Pediatr Transplant; 2005 Oct; 9(5):618-21. PubMed ID: 16176419
[TBL] [Abstract][Full Text] [Related]
9. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
Lang P; Pfeiffer M; Müller I; Schumm M; Ebinger M; Koscielniak E; Feuchtinger T; Föll J; Martin D; Handgretinger R
Klin Padiatr; 2006; 218(6):321-6. PubMed ID: 17080334
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
Suminoe A; Matsuzaki A; Hattori H; Koga Y; Hara T
Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
13. Induction of two distinct natural killer-cell populations, activated T cells and antineoplastic cytokines, by interleukin-2 therapy in children with solid tumors.
Dilloo D; Laws HJ; Hanenberg H; Körholz D; Nürnberger W; Burdach SE
Exp Hematol; 1994 Oct; 22(11):1081-8. PubMed ID: 7925775
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
15. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II study of interleukin-2 after high-dose chemotherapy and autologous bone marrow transplantation in poorly responding neuroblastoma.
Valteau-Couanet D; Rubie H; Meresse V; Farace F; Brandely M; Hartmann O
Bone Marrow Transplant; 1995 Oct; 16(4):515-20. PubMed ID: 8528166
[TBL] [Abstract][Full Text] [Related]
18. Biology and therapy of pediatric malignant solid tumors.
Marina N
Cancer Chemother Biol Response Modif; 1999; 18():550-89. PubMed ID: 10800501
[No Abstract] [Full Text] [Related]
19. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
20. Functional and molecular characterization of interleukin-2 transgenic Ewing tumor cells for in vivo immunotherapy.
Staege MS; Hansen G; Baersch G; Burdach S
Pediatr Blood Cancer; 2004 Jul; 43(1):23-34. PubMed ID: 15170886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
